Dual-Acting Peptides Target EZH2 and AR: A New Paradigm for Effective Treatment of Castration-Resistant Prostate Cancer

Zhengyang Han(University of Toledo), Lirim Shemshedini(University of Toledo)
Endocrinology
October 26, 2022
Cited by 6


Related Papers